De novo design of a homo-trimeric amantadine-binding protein

13Citations
Citations of this article
76Readers
Mendeley users who have this article in their library.

Abstract

The computational design of a symmetric protein homo-oligomer that binds a symmetry-matched small molecule larger than a metal ion has not yet been achieved. We used de novo protein design to create a homo-trimeric protein that binds the C3 symmetric small molecule drug amantadine with each protein monomer making identical interactions with each face of the small molecule. Solution NMR data show that the protein has regular three-fold symmetry and undergoes localized structural changes upon ligand binding. A high-resolution X-ray structure reveals a close overall match to the design model with the exception of water molecules in the amantadine binding site not included in the Rosetta design calculations, and a neutron structure provides experimental validation of the computationally designed hydrogen-bond networks. Exploration of approaches to generate a small molecule inducible homo-trimerization system based on the design highlight challenges that must be overcome to computationally design such systems.

Cite

CITATION STYLE

APA

Park, J., Selvaraj, B., McShan, A. C., Boyken, S. E., Wei, K. Y., Oberdorfer, G., … Baker, D. (2019). De novo design of a homo-trimeric amantadine-binding protein. ELife, 8. https://doi.org/10.7554/eLife.47839

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free